FAQ

PIXY321 fusion protein, recombinant

Known as: PIXY321, PIXY321 protein, recombinant, pIXY 321 protein, recombinant 
 

Topic mentions per year

Topic mentions per year

1991-2005
02419912005

Related topics

Related topics

4 relations

Broader (4)

Granulocyte-Macrophage Colony-Stimulating FactorInterleukin-3Recombinant Fusion Proteinsmilodistim

Related mentions per year

Related mentions per year

1977-2018
197019801990200020102020
PIXY321 fusion protein, recombinant
Granulocyte-Macrophage Colony-Stimulating Factor
Interleukin-3
Recombinant Fusion Proteins
milodistim

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
Thrombopoietin and chemokine mRNA expression in patient post-chemotherapy and in vitro cytokine-treated marrow stromal cell layers.
CD34(+) cells and megakaryocyte progenitors were lower in marrow from patients after hematological recovery from the first cycle… (More)
Is this relevant?
1999
1999
Abrogation of the hematological and biological activities of the interleukin-3/granulocyte-macrophage colony-stimulating factor fusion protein PIXY321 by neutralizing anti-PIXY321 antibodies in…
This dose-escalation study was performed to evaluate the hematologic activity, biological effects, immunogenicity, and toxicity… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
1999
1999
Randomized, double-blind, placebo-controlled trial to evaluate the hematopoietic growth factor PIXY321 after moderate-dose fluorouracil, doxorubicin, and cyclophosphamide in stage II and III breast…
PURPOSE To measure the effect of PIXY321 (granulocyte-macrophage colony-stimulating factor/interleukin-3 S. cerevisiae fusion… (More)
Is this relevant?
1998
1998
Phase I/II trial of PIXY321 (granulocyte-macrophage colony stimulating factor/interleukin-3 fusion protein) for treatment of inherited and acquired marrow failure syndromes.
Fourteen paediatric patients with advanced amegakaryocytic thrombocytopenia (AMT) or other bone marrow (BM) failure syndromes… (More)
Is this relevant?
1996
1996
Phase I trial of recombinant fusion protein PIXY321 for mobilization of peripheral-blood cells.
PURPOSE Mobilization of peripheral-blood cells (PBC) with cytokines alone results in rapid hematopoietic recovery and avoids the… (More)
Is this relevant?
1996
1996
Mechanism of transcriptional activation of the immediate early gene Egr-1 in response to PIXY321.
Studies with the granulocyte-macrophage colony-stimulating factor (GM-CSF)/interleukin-3 (IL-3) fusion protein, PIXY321… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
Is this relevant?
1996
1996
Phase I/II trial of PIXY321 to enhance engraftment following autologous bone marrow transplantation for lymphoid malignancy.
PURPOSE A phase I/II study of PIXY321 following high-dose therapy (HDT) and autologous bone marrow transplantation (ABMT) was… (More)
Is this relevant?
1995
1995
In vivo biologic effects of PIXY321, a synthetic hybrid protein of recombinant human granulocyte-macrophage colony-stimulating factor and interleukin-3 in cancer patients with normal hematopoiesis: a…
PIXY321 is a novel fusion protein of recombinant human granulocyte-macrophage colony-stimulating factor and interleukin-3 that… (More)
Is this relevant?
1994
1994
Effects of PIXY321, a granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein, on chemotherapy-induced multilineage myelosuppression in patients with sarcoma.
PURPOSE To evaluate the clinical safety and ability of PIXY321, a novel fusion protein of recombinant human granulocyte… (More)
Is this relevant?
1992
1992
The In Vitro Effects of Stem Cell Factor and PIXY321 on Myeloid Progenitor Formation (CFU-GM) from Immunomagnetic Separated CD34+ Cord Blood
ABSTRACT: Two novel cytokines, stem cell factor (SCF) and PIXY321 (a fusion protein, granulocyte macrophage colony-stimulating… (More)
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?